Literature DB >> 12696018

The effect of quinine on the electroretinograms of children with pediatric cerebral malaria.

Jonathan Lochhead1, Armand Movaffaghy, Benedetto Falsini, Peter A Winstanley, Edward K Mberu, Charles E Riva, Malcolm E Molyneux, Terrie E Taylor, Simon P Harding.   

Abstract

To investigate the effects of quinine on the electroretinograms (ERGs) of children with cerebral malaria (CM), we recruited subjects during a single malaria season in Blantyre, Malawi. Seventy ERG investigations were performed, on 34 children with CM. Time recorded from completion of the most recent quinine infusion was termed "quinine elapsed time" (QET). In a subgroup of 16 children, whole-blood quinine concentrations were estimated in a sample of capillary blood, for validation. A significant positive association was found between QET and both maximal-response A-wave amplitude (MRAWA; P=.03) and cone A-wave amplitude (P=.04). Longitudinal analysis demonstrated a significant trend of increasing MRAWA with increasing QET (P=.03). Parenteral quinine administered in therapeutic doses to a pediatric population appears to cause a transient depression in photoreceptor function. No evidence of ocular quinine toxicity was found at the therapeutic doses used.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12696018     DOI: 10.1086/374058

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  A Case of Quinine Induced Blindness.

Authors:  A Sagar; S Mukherji
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Neurovascular sequestration in paediatric P. falciparum malaria is visible clinically in the retina.

Authors:  Valentina Barrera; Ian James Callum MacCormick; Gabriela Czanner; Paul Stephenson Hiscott; Valerie Ann White; Alister Gordon Craig; Nicholas Alexander Venton Beare; Lucy Hazel Culshaw; Yalin Zheng; Simon Charles Biddolph; Danny Arnold Milner; Steve Kamiza; Malcolm Edward Molyneux; Terrie Ellen Taylor; Simon Peter Harding
Journal:  Elife       Date:  2018-03-26       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.